Atrial fibrillation and heart failure: A bad combination

Current Opinion in Cardiology

Volumn 30, Issue 2, 2015, Pages 161-167

  Leong Sit, Peter ^a   Tang, Anthony S L ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Ablation; Atrial fibrillation; Heart failure; Prognosis; Treatment

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN;

ABLATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY; CATHETER ABLATION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART RATE; HEART RHYTHM; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; IMPLANTATION; META ANALYSIS (TOPIC); MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 84927556903     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0000000000000144     Document Type: Review

References (39)

1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics: 2014 update - a report from the American Heart Association. Circulation 2014; 129:e28-e292.
2. Camm AJ, Obel OA. Epidemiology and mechanism of atrial fibrillation and atrial flutter. Am J Cardiol 1996; 78 (8A):3-11.
3. Braunwald E. Shattuck lecture: cardiovascular medicine at the turn of the millennium - triumphs, concerns, and opportunities. N Engl J Med 1997; 337:1360-1369.
4. Cleland JG, Swedberg K, Follath F, et al. The EuroHeart Failure survey programme: a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003; 24:442-463.
5. Nieuwlaat R, Capucci A, Camm AJ, et al. Atrial fibrillation management: a prospective survey in ESC member countries - the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2005; 26:2422-2434.
6. Aleong RG, Sauer WH, Davis G, Bristow MR. New onset atrial fibrillation predicts heart failure progression. Am J Med 2014; 127:963-971.
7. Guglin M, Chen R. How much atrial fibrillation causes symptoms of heart failure? Int J Clin Pract 2014; 68:453-457.
8. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347:1825-1833.
9. Imai K, Okura H, Tamada T, et al. Prediction of congestive heart failure in patients with non valvular atrial fibrillation. Intern Med 2014; 53:7-12.
10. Khazanie P, Liang L, Qualls LG, et al. Outcomes of Medicare beneficiaries with heart failure and atrial fibrillation. JACC Heart Fail 2014; 2:41-48.
11. Ogah OS, Stewart S, Falase AO, et al. Predictors of rehospitalisation in patients admitted with heart failure in Abeokuta, Nigeria: Data from the Abeokuta Heart failure Registry. J Card Fail 2014; 20:833-840.
12. Oluleye OW, Rector TS, Win S, et al. History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction. Circ Heart Fail 2014; 7:960-966.
13. Lund LH, Donal E, Oger E, et al. Association between cardiovascular vs. noncardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction. Eur J Heart Fail 2014; 16:992-1001.
14. Mamas MA, Caldwell JC, Chacko S, et al. A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure. Eur J Heart Fail 2009; 11:676-683.
15. Bajaj NS, Bhatia V, Sanam K, et al. Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in communitydwelling older adults. Am J Cardiol 2014; 114:909-913.
16. Taillandier S, Brunet Bernard A, Lallemand B, et al. Prognosis in patients hospitalized with permanent and nonpermanent atrial fibrillation in heart failure. Am J Cardiol 2014; 113:1189-1195.
17. Eapen ZJ, Greiner MA, Fonarow GC, et al. Associations between atrial fibrillation and early outcomes of patients with heart failure and reduced or preserved ejection fraction. Am Heart J 2014; 167:369-375; e2.
18. Reinier K, Marijon E, Uy-Evanado A, et al. The association between atrial fibrillation and sudden cardiac death: the relevance of heart Fail. JACC Heart Fail 2014; 2:221-227.
19. Shah M, Avgil Tsadok M, Jackevicius CA, et al. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients >/=65 years of age with versus without heart failure. Am J Cardiol 2014; 114:401-406.
20. Mulder BA, Van Veldhuisen DJ, Crijns HJ, et al. Digoxin in patients with permanent atrial fibrillation: data from the RACE II study. Heart Rhythm 2014; 11:1543-1550.
21. Rodriguez-Manero M, Otero-Ravina F, Garcia-Seara J, et al. Outcomes of a contemporary sample of patients with atrial fibrillation taking digoxin: results from the AFBAR study. Revista Espanola de Cardiologia 2014; 67:890-897.
22. Hood WB Jr, Dans AL, Guyatt GH, et al. Digitalis for treatment of heart failure in patients in sinus rhythm. Cochrane Database Syst Rev 2014; 4:CD002901.
23. Mulder BA, Van Veldhuisen DJ, Crijns HJ, et al. Lenient vs. strict rate control in patients with atrial fibrillation and heart failure: a posthoc analysis of the RACE II study. Eur J Heart Fail 2013; 15:1311-1318.
24. Kobayashi S, Murakami W, Myoren T, et al. A low-dose beta1-blocker effectively and safely slows the heart rate in patients with acute decompensated heart failure and rapid atrial fibrillation. Cardiology 2014; 127:105-113.
25. Kotecha D, Holmes J, Krum H, et al. Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet 2014. [Epub ahead of print]
26. Van Gelder IC, Groenveld HF, Crijns HJ, et al. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 2010; 362:1363-1373.
27. Cullington D, Goode KM, Zhang J, et al. Is heart rate important for patients with heart failure in atrial fibrillation? JACC Heart Fail 2014; 2:213-220.
28. Kato N, Kinugawa K, Teruhiko I, et al. Differential impacts of achieved heart rate and achieved dose of beta-blocker on clinical outcomes in heart failure with and without atrial fibrillation. Int J Cardiol 2014; 173:331-333.
29. Cadrin-Tourigny J, Wyse DG, Roy D, et al. Efficacy of amiodarone in patients with atrial fibrillation with and without left ventricular dysfunction: a pooled analysis of AFFIRM and AF-CHF trials. J Cardiovasc Electrophysiol 2014; 25:1306-1313.
30. Hohnloser SH, Connolly SJ, John Camm A, et al. An individual patient-based meta-analysis of the effects of dronedarone in patients with atrial fibrillation. Europace 2014; 16:1117-1124.
31. Hohnloser SH, Halperin JL, Camm AJ, et al. Interaction between digoxin and dronedarone in the PALLAS trial. Circ Arrhythm Electrophysiol 2014. [Epub ahead of print]
32. Poulin F, Khairy P, Roy D, et al. Atrial fibrillation and congestive heart failure: a cost analysis of rhythm-control vs. rate-control strategies. Can J Cardiol 2013; 29:1256-1262.
33. Hunter RJ, Berriman TJ, Diab I, et al. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol 2014; 7:31-38.
34. Nedios S, Sommer P, Dagres N, et al. Long-term follow-up after atrial fibrillation ablation in patients with impaired left ventricular systolic function: the importance of rhythm and rate control. Heart Rhythm 2014; 11:344-351.
35. Bortone A, Pujadas-Berthault P, Karam N, et al. Catheter ablation in selected patients with depressed left ventricular ejection fraction and persistent atrial fibrillation unresponsive to current cardioversion. Europace 2013; 15:1574-1580.
36. Anselmino M, Matta M, D'Ascenzo F, et al. Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol 2014. [Epub ahead of print]
37. van Boven N, Theuns D, Bogaard K, et al. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks. J Cardiovasc Electrophysiol 2013; 24:1116-1122.
38. Ruwald AC, Pietrasik G, Goldenberg I, et al. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT- CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). J Am Coll Cardiol 2014; 63:1190-1197.
39. Yin J, Hu H, Wang Y, et al. Effects of atrioventricular nodal ablation on permanent atrial fibrillation patients with cardiac resynchronization therapy: a systematic review and meta-analysis. Clin Cardiol 2014; 37:707-715.